Levocetirizine 2HCl is a third-generation non-sedative antihistamine, developed from the second-generation antihistamine cetirizine.

Amlexanox is a selective inhibitor of TBK1 and IKKε with IC50 values of ~1-2 μM.

Montelukast Sodium is a potent, selective and competitive LTR1 antagonist with IC50 value < 5 nM, possesssing anti-inflammatory and bronchodilating activities.

Cetirizine 2HCl, a metabolite of hydroxyzine, is racemic selective and inverse agonist of H1 receptor used in the treatment of allergies and hay fever.

Olopatadine HCl can block the release of histamine (IC50 = 559 µM) and stabilize mast cell.